Review of the Evidence and Qualifications Regarding the Effects of Hallucinogenic Drugs on Chromosomes and Embryos
Abstract
Laboratory studies of the effects of hallucinogenic drugs on chromosomes and developing embryos are reviewed. The author concludes that at present there is no adequate evidence that these drugs cause chromosomal damage in vivo or adversely affect progeny as a result of chromosomal changes. However, these drugs when taken early (but not late) in pregnancy appear to have a teratogenic effect.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
